Cancer

1. TAKEDA Y, Imamura H, Ichida H, Yoshioka R, et al
   Re-evaluating the diagnostic value of alpha-fetoprotein for hepatocellular carcinoma in the direct-acting antiviral era.
   Cancer. 2026;132:e70308.
   

   >> Share

   
   

   
   Clin Infect Dis

2. BIXLER D, Bennett CC, Yin S, Thomson A, et al
   Fatal Overdose, Acute Viral Hepatitis, and Human Immunodeficiency Virus Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023.
   Clin Infect Dis. 2026 Feb 11:ciaf730. doi: 10.1093.
   

   >> Share

   
   

   
   Gut

3. BARTOSCH B, Lauer GM
   Catch me if you can! Is there protection from HCV (re)infection?
   Gut. 2026 Feb 11:gutjnl-2025-337209. doi: 10.1136/gutjnl-2025-337209.
   

   >> Share

   
   

   
   Hepatology

4. PRAWIRA A, Hilleke M, Chen M, Roninson IB, et al
   CDK8 and CDK19 Mediator kinases are required for hepatitis delta virus replication.
   Hepatology. 2026 Feb 10. doi: 10.1097/HEP.0000000000001690.
   

   >> Share

   
   
5. LUCIFORA J, Negro F
   Shedding new light on the chicken-and-egg dilemma of hepatitis delta virus (HDV) replication initiation.
   Hepatology. 2026 Feb 13. doi: 10.1097/HEP.0000000000001705.
   

   >> Share

   
   

   
   J Clin Microbiol

6. PEREZ-GARCIA F, Virseda-Berdices A, Pita-Martinez C, Munoz Monte M, et al
   Challenges in accurate HDV RNA quantification: inter-assay variability and the impact of thermal shock.
   J Clin Microbiol. 2026;64:e0151725.
   

   >> Share

   
   

   
   J Hepatol

7. TAK KY, Lee J, Jang JW, Lee SK, et al
   Incidence and Risk Stratification of Hepatitis B Reactivation in Patients Receiving Anti-CD38 Monoclonal Antibody Therapy.
   J Hepatol. 2026 Feb 13:S0168-8278(26)00067-X. doi: 10.1016/j.jhep.2026.
   

   >> Share

   
   
8. WANG J, Zhang S, Zhu C, Wu C, et al
   Discrepancies in Treatment Eligibility Across International Guidelines for Chronic Hepatitis B.
   J Hepatol. 2026 Feb 12:S0168-8278(26)00068-1. doi: 10.1016/j.jhep.2026.
   

   >> Share

   
   

   
   J Med Virol

9. PANAJOTOV J, Giersch K, Pfluger LS, Norz D, et al
   Development of a Fully Automated, High-Throughput Molecular Assay for Detection of Rat Hepatitis E Virus in Routine Diagnostics.
   J Med Virol. 2026;98:e70824.
   

   >> Share

   
   
10. HUANG A, Xu X, Zhang Q
    Global, Regional, and National Time Trends in Incidence for Hepatitis A, 1990-2021: A Systematic Analysis for the Global Burden of Disease 2021 Study.
    J Med Virol. 2026;98:e70838.
    

    >> Share

    
    

    
    J Viral Hepat

11. ELSABAAWY M, Naguib M, Magdy M, Shaban A, et al
    Refining Risk Stratification for Oesophageal Varices in HCV-Related Cirrhosis: A Comprehensive Analysis of the Albumin Platelet Product and Elastography Biomarkers.
    J Viral Hepat. 2026;33:e70146.
    

    >> Share

    
    
12. GUERRA-VELOZ MF, Shah S, Emmanouil B, Olsen M, et al
    Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC.
    J Viral Hepat. 2026;33:e70148.
    

    >> Share

    
    
13. YOU C, Diao Y, Tang J, Tang J, et al
    Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination.
    J Viral Hepat. 2026;33:e70150.
    

    >> Share

    
    

    
    PLoS One

14. SULAIMAN AS, Nugroho P, Bahri DR, Rachmani D, et al
    Diagnostic concordance of GeneXpert HCV VL fingerstick and GeneXpert HCV viral load with RT-PCR in POCT settings among hemodialysis patients.
    PLoS One. 2026;21:e0324671.
    

    >> Share

    
    
15. WANG C, Chen Y, Xiao H, Cai J, et al
    Metabolomics-guided machine learning reveals diagnostic and mechanistic biomarkers in CHB with MASLD.
    PLoS One. 2026;21:e0331529.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share